The effects of methylene blue infusion on gastric tonometry and intestinal fatty acid binding protein levels in septic shock patients

Journal of Critical Care

Volumn 25, Issue 2, 2010, Pages 358.e1-358.e7

  van Haren, Frank M P ^a   Pickkers, Peter ^b   Foudraine, Norbert ^c   Heemskerk, Suzanne ^b   Sleigh, James ^a   van der Hoeven, Johannes G ^b  

^a WAIKATO HOSPITAL   (New Zealand)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VIECURI MEDICAL CENTER   (Netherlands)

Author keywords

IFABP; Methylene blue; Nitric oxide; Septic shock; Tonometry

Indexed keywords

CREATININE; FATTY ACID BINDING PROTEIN; HYDROCORTISONE; METHYLENE BLUE; NORADRENALIN;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; BACTERIAL INFECTION; CELL DAMAGE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; FEMALE; FLUID RESUSCITATION; HEMATOCRIT; HEMODYNAMICS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERBILIRUBINEMIA; INTENSIVE CARE UNIT; INTESTINE PERFUSION; MALE; MEAN ARTERIAL PRESSURE; METHEMOGLOBINEMIA; MUCOSA CELL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; SEPTIC SHOCK; SIDE EFFECT; STOMACH MUCOSA; STOMACH PRESSURE; TONOMETRY; URINARY EXCRETION; URINE COLOR;

EID: 77953289771     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2010.02.008     Document Type: Article

References (35)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310.
2. Alberti C., Brun-Buisson C., Goodman S.V., et al. Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med 2003, 168:77-84.
3. Vincent J.L., Zhang H., Szabo C., et al. Effects of nitric oxide in septic shock. Am J Respir Crit Care Med 2000, 161:1781-1785.
4. Lopez A., Lorente J.A., Steingrub J., et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004, 32:21-30.
5. Mayer B., Brunner F., Schmidt K. Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol 1993, 45:367-374.
6. Marczin N., Ryan U.S., Catravas J.D. Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion. J Pharmacol Exp Ther 1992, 263:170-179.
7. Kirov M.Y., Evgenov O.V., Evgenov N.V., et al. Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study. Crit Care Med 2001, 29:1860-1867.
8. Kwok E.S., Howes D. Use of methylene blue in sepsis: a systematic review. J Intensive Care Med 2006, 21:359-363.
9. Memis D., Karamanlioglu B., Yuksel M., et al. The influence of methylene blue infusion on cytokine levels during severe sepsis. Anaesth Intensive Care 2002, 30:755-762.
10. Mokhlesi B., Leikin J.B., Murray P., et al. Adult toxicology in critical care: Part II: specific poisonings. Chest 2003, 123:897-922.
11. van Haren F.M., Sleigh J.W., Pickkers P., et al. Gastrointestinal perfusion in septic shock. Anaesth Intensive Care 2007, 35:679-694.
12. Matheson P.J., Wilson M.A., Garrison R.N. Regulation of intestinal blood flow. J Surg Res 2000, 93:182-196.
13. Levy B., Gawalkiewicz P., Vallet B., et al. Gastric capnometry with air-automated tonometry predicts outcome in critically ill patients. Crit Care Med 2003, 31:474-480.
14. Chmurzynska A. The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism. J Appl Genet 2006, 47:39-48.
15. Pelsers M.M., Hermens W.T., Glatz J.F. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta 2005, 352:15-35.
16. Niewold T.A., Meinen M., van der Meulen J. Plasma intestinal fatty acid binding protein (I-FABP) concentrations increase following intestinal ischemia in pigs. Res Vet Sci 2004, 77:89-91.
17. Lieberman J.M., Marks W.H., Cohn S., et al. Organ failure, infection, and the systemic inflammatory response syndrome are associated with elevated levels of urinary intestinal fatty acid binding protein: study of 100 consecutive patients in a surgical intensive care unit. J Trauma 1998, 45:900-906.
18. Gollin G., Zieg P.M., Cohn S.M., et al. Intestinal mucosal injury in critically ill surgical patients: preliminary observations. Am Surg 1999, 65:19-21.
19. Levy M.M., Fink M.P., Marshall J.C., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003, 29:530-538.
20. Kirsch I.R., Cohen H.J. Heinz body hemolytic anemia from the use of methylene blue in neonates. J Pediatr 1980, 96:276-278.
21. Curry S. Methemoglobinemia. Ann Emerg Med 1982, 11:214-221.
22. Huybregts R.A., Morariu A.M., Rakhorst G., et al. Attenuated renal and intestinal injury after use of a mini-cardiopulmonary bypass system. Ann Thorac Surg 2007, 83:1760-1766.
23. van Haren F.M., Rozendaal F.W., van der Hoeven J.G. The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest 2003, 124:2256-2260.
24. Heemskerk S., van Haren F.M., Foudraine N.A., et al. Short-term beneficial effects of methylene blue on kidney damage in septic shock patients. Intensive Care Med 2008, 34:350-354.
25. Perner A., Faber T. Stroke volume variation does not predict fluid responsiveness in patients with septic shock on pressure support ventilation. Acta Anaesthesiol Scand 2006, 50:1068-1073.
26. Michard F., Teboul J.L. Predicting fluid responsiveness in ICU patients: a critical analysis of the evidence. Chest 2002, 121:2000-2008.
27. Stawicki S.P., Sims C., Sarani B., et al. Methylene blue and vasoplegia: who, when, and how?. Mini Rev Med Chem 2008, 8:472-490.
28. LeDoux D., Astiz M.E., Carpati C.M., et al. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000, 28:2729-2732.
29. Asfar P., De Backer D., Meier-Hellmann A., et al. Clinical review: influence of vasoactive and other therapies on intestinal and hepatic circulations in patients with septic shock. Crit Care 2004, 8:170-179.
30. Meile T., Glatzle J., Habermann F.M., et al. Nitric oxide synthase inhibition results in immediate postoperative recovery of gastric, small intestinal and colonic motility in awake rats. Int J Colorectal Dis 2006, 21:121-129.
31. Demirbilek S., Sizanli E., Karadag N., et al. The effects of methylene blue on lung injury in septic rats. Eur Surg Res 2006, 38:35-41.
32. Donati A., Conti G., Loggi S., et al. Does methylene blue administration to septic shock patients affect vascular permeability and blood volume?. Crit Care Med 2002, 30:2271-2277.
33. Sweet G., Standiford S.B. Methylene-blue-associated encephalopathy. J Am Coll Surg 2007, 204:454-458.
34. Kessler M.R., Eide T., Humayun B., et al. Spurious pulse oximeter desaturation with methylene blue injection. Anesthesiology 1986, 65:435-436.
35. Iskit A.B., Guc O. Effects of endothelin and nitric oxide on organ injury, mesenteric ischemia, and survival in experimental models of septic shock. Acta Pharmacol Sin 2003, 24:953-957.